BMS
Brummer Multi-Strategy Portfolio holdings
AUM
$16.5M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$16.5M
AUM Growth
+$11.1M
(+201%)
Holding
13
Top Buys
| 1 | +$3.31M | |
| 2 | +$1.82M | |
| 3 | +$1.78M | |
| 4 |
ABVX
Abivax
ABVX
|
+$1.57M |
| 5 |
Maravai LifeSciences
MRVI
|
+$1.54M |
Sector Composition
| 1 | Healthcare | 78.99% |
| 2 | Real Estate | 21.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Newmark Group
NMRK
$2.62B
| $3.48M | 21.01% |
200,493
+10,974
|
|
||
2
Cigna
CI
$76.4B
| $3.25M | 19.66% |
+11,818
|
|
||
3
Arvinas
ARVN
$852M
| $1.97M | 11.93% |
+166,342
|
|
||
|
ABVX
4
Abivax
ABVX
$9.59B
| $1.94M | 11.72% |
+14,375
|
|
||
5
IQVIA
IQV
$30.3B
| $1.84M | 11.15% |
+8,183
|
|
||
|
6
Maravai LifeSciences
MRVI
$516M
| $1.49M | 8.99% |
+457,707
|
|
||
7
Becton Dickinson
BDX
$50.2B
| $1M | 6.07% |
5,176
+4,706
|
|
||
8
AtaiBeckley Inc
ATAI
$1.32B
| $961K | 5.81% |
+234,915
|
|
||
9
Soleno Therapeutics
SLNO
$2.1B
| $405K | 2.45% |
+8,741
|
|
||
|
KLTO
10
Klotho Neurosciences
KLTO
$38.6M
| $175K | 1.06% |
+606,757
|
|
||
11
Foghorn Therapeutics
FHTX
$333M
| $25.4K | 0.15% |
+4,708
|
|
||
12
Colliers International
CIGI
$6.05B
| – | – |
-4,426
|
|
||
13
PTC Therapeutics
PTCT
$5.47B
| – | – |
-19,142
|
|